Chung Wiley, Kazemi Pooya, Ko David, Sun Clare, Brown Carl J, Raval Manoj, Phang Terry
Division of General Surgery, St Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
Am J Surg. 2009 May;197(5):604-8. doi: 10.1016/j.amjsurg.2008.12.013.
High transsphincteric fistulas are difficult to treat because fistulotomy of involved sphincter muscle results in incontinence. We compare our outcomes for anal fistula plug, fibrin glue, advancement flap closure, and seton drain insertion.
This is a retrospective study of patients treated for high transsphincteric anal fistulas. The primary outcome was full healing at 12 weeks postoperatively.
Between 1997 and 2008, 232 patients with anal fistula were identified in the St. Paul's Hospital Anal Fistula Database. Postoperative healing rates at the 12-week follow-up for the fistula plug, fibrin glue, flap advancement, and seton drain groups were 59.3%, 39.1%, 60.4%, and 32.6%, respectively (P < .0001).
Closure of the primary fistula opening using a biological anal fistula plug and anal flap advancement result in similar fistula healing rates in patients with high transsphincteric fistulae. These 2 strategies are superior to seton placement and fibrin glue. Given the low morbidity and relative simplicity of the procedure, the anal fistula plug is a viable alternative treatment for patients with high transsphincteric anal fistulas.
高位经括约肌肛瘘难以治疗,因为对受累括约肌进行瘘管切开术会导致大便失禁。我们比较了肛瘘栓、纤维蛋白胶、推进皮瓣闭合术和挂线引流术的治疗效果。
这是一项对高位经括约肌肛瘘患者进行的回顾性研究。主要观察指标是术后12周完全愈合情况。
1997年至2008年期间,在圣保罗医院肛瘘数据库中识别出232例肛瘘患者。肛瘘栓组、纤维蛋白胶组、皮瓣推进组和挂线引流组在12周随访时的术后愈合率分别为59.3%、39.1%、60.4%和32.6%(P <.0001)。
使用生物肛瘘栓闭合原发性瘘口和推进肛门皮瓣,在高位经括约肌肛瘘患者中可获得相似的瘘管愈合率。这两种策略优于挂线术和纤维蛋白胶。鉴于该手术发病率低且相对简单,肛瘘栓是高位经括约肌肛瘘患者一种可行的替代治疗方法。